AMGEN : BeiGene Announces the Approval in China of KYPROLIS (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma
MarketScreener,
BEIJING & CAMBRIDGE, Mass. - (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and…